Cumberland Pharmaceuticals CPIX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $11.01M-3.8% | $11.44M-24.7% | $15.2M-5.5% | $16.09M+6.5% | $15.11M-15.9% | ||
| $14.26M-15.8% | $16.94M+62.5% | $10.43M+1.1% | $10.32M-1.6% | $10.49M-10.4% | ||
| $9.88M+6.7% | $9.25M+0.8% | $9.18M-3.6% | $9.53M-4.2% | $9.94M-9.7% | ||
| $32.79M-11.5% | $37.06M+23.8% | $29.94M-4.1% | $31.21M-2.1% | $31.88M-12.6% | ||
| $237.38K-10.3% | $264.72K-9.8% | $293.38K-1.5% | $297.79K-0.3% | $298.74K+7.7% | ||
| $914K0.0% | $914K0.0% | $914K0.0% | $914K0.0% | $914K0.0% | ||
| $12.79M-8.8% | $14.03M-6.5% | $15.01M-6.1% | $15.99M-5.9% | $16.99M-5.5% | ||
| —— | —— | —— | —— | —— | ||
| $71M-7.6% | $76.82M+16.6% | $65.9M-3.0% | $67.91M-2.9% | $69.94M-7.5% | ||
| $16.54M-10.9% | $18.57M+34.2% | $13.83M+2.9% | $13.45M-3.5% | $13.93M+0.1% | ||
| —— | —— | —— | —— | —— | ||
| $34.49M-6.1% | $36.74M+51.2% | $24.31M+1.4% | $23.97M-6.1% | $25.52M-19.3% | ||
| $49.69M-4.9% | $52.28M+30.4% | $40.1M-0.3% | $40.23M-3.3% | $41.6M-21.6% | ||
| $51.73M+0.1% | $51.68M+0.3% | $51.51M+0.1% | $51.44M+0.1% | $51.37M+9.7% | ||
| -$30.09M-12.3% | -$26.8M-5.6% | -$25.39M-8.3% | -$23.45M-3.3% | -$22.71M+5.2% | ||
| $21.64M-13.0% | $24.88M-4.7% | $26.12M-6.7% | $27.99M-2.3% | $28.66M+25.4% | ||
| $71M-7.6% | $76.82M+16.6% | $65.9M-3.0% | $67.91M-2.9% | $69.94M-7.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cumberland Pharmaceuticals's total assets?
- Cumberland Pharmaceuticals (CPIX) holds $71.0M in total assets, up 1.5% year over year.
- How much debt does Cumberland Pharmaceuticals have?
- Cumberland Pharmaceuticals carries $4.8M in total debt against $21.6M of shareholders' equity, a debt-to-equity ratio of 0.22.
- How much cash does Cumberland Pharmaceuticals have?
- Cumberland Pharmaceuticals holds $11.0M in cash and equivalents.
- Can Cumberland Pharmaceuticals cover its short-term obligations?
- Its current ratio is 0.95 — current liabilities exceed current assets.
- Where does Cumberland Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
